Heska shares soar on 2Q earnings gains

LOVELAND – Shares of Heska Corp. (Nasdaq: HSKA), which makes veterinary diagnostic and specialty products, were up more than 11 percent in Wednesday afternoon trading after the company posted major year-over-year gains in net income and revenue for the second quarter.

The Loveland-based company reported net income for the period ending June 30 of $2.5 million, or 35 cents per diluted share, more than double the marks of $1.2 million and 17 cents per share for the same period a year earlier.

Revenue for the second quarter, meanwhile, came in at $30 million, up 25 percent over a year ago.

SPONSORED CONTENT

How dispatchable resources enable the clean energy transition

Platte River must prepare for the retirement of 431 megawatts (MW) of dispatchable, coal-fired generation by the end of the decade and address more frequent extreme weather events that can bring dark calms (periods when there is no sun or wind).

Heska’s Core Companion Animal Health segment saw sales rise 18 percent to $24.5 million on strong performance from blood testing instruments, consumables and digital imaging, company officials said. The company’s Other Vaccines, Pharmaceuticals and Products segment, meanwhile, climbed 74 percent to $5.5 million.

The company finished the second quarter with $6.7 million in cash. Stockholder’s equity increased from $63.5 million as of Dec. 31 to $75.7 million as of June 30.

As the trading day neared its close Wednesday, Heska shares were trading at $48.50 apiece, up $4.89 from Tuesday’s close.